Oxford Asset Management’s West Pharmaceutical WST Stock Holding History

Oxford Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510K	Buy	1,422 +431	+43%	+$132K	0.25%	111
2026 Q1	$248K	Buy	+991	New	+$247K	0.1%	310
2020 Q1	–	Sell	-4,937	Closed	-$742K	–	1331
2019 Q4	$742K	Sell	4,937 -14,007	-74%	-$2.04M	0.02%	1034
2019 Q3	$2.69M	Buy	18,944 +10,133	+115%	+$1.4M	0.06%	389
2019 Q2	$1.1M	Buy	+8,811	New	+$1.04M	0.02%	924
2019 Q1	–	Sell	-6,484	Closed	-$636K	–	2028
2018 Q4	$636K	Buy	+6,484	New	+$704K	0.02%	1089

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Oxford Asset Management's WST Position: Q2 2026 in Review

Oxford Asset Management increased its West Pharmaceutical (WST) stake by 43% in Q2 2026, buying an estimated $132K and bringing the position to 1,422 shares worth $510K. The position accounts for 0.25% of the portfolio, ranked #111.

Oxford Asset Management first reported a position in WST in Q4 2018 and has held it in 6 quarters since. The position peaked at $2.69M in Q3 2019. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Oxford Asset Management held 1,422 shares of West Pharmaceutical worth $510K as of Q2 2026.
Oxford Asset Management bought 431 West Pharmaceutical shares in Q2 2026, an estimated $132K.
West Pharmaceutical made up 0.25% of Oxford Asset Management's portfolio in Q2 2026, its #111 holding.
Oxford Asset Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 6 quarters since.
Oxford Asset Management's West Pharmaceutical position peaked at $2.69M in Q3 2019.
833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.